but wondered if any interaction term was assessed in the model four? Since this data is arisen from Randomised trial, I wonder why the authors haven't sited the consort statement. There is no mention of how missing observations was dealt within the analysis? We would be interested in further exploration of the differences in risk relationships between races. In particular, we would like to see the data for both races combined into a single model for each outcome with a test for the interaction between race and each outcome. The baseline visit needs clarification. Was this the first available visit in clinic? Date of the first available ECG? Where the 3 outcome competing? Could a subject have all the three outcomes or 2 etc? If that was the case could a competing risk analyses be appropriate? Results Figure 1 -It will be helpful to see a comparison ( without statistical test, just the descriptive data) of the clinical variables of those patients with and without SDNN/rMSSD. There is some inconsistence with this figure compared to one of the authors previous publication ( Ref 16) . In that paper the authors report 646 subjects with a missing or poor quality of baseline ECG, while in this paper is only 207? But the number of subjects in the trial is the same 5472 in both articles. Could the authors explain the discrepancies? I would thought the subjects who qualify in this analysis should be those with baseline ECG ( i.e. 4,826-number from the old paper) then to subsequently restrict to the PI or NNRTI regiment? Since p-values are included in table one, the test that is been used should be mentioned in the statically section. I would recommend that the results in the table 2 and supplementary table two should be presented coefficient with 95% confidence intervals, instead of coefficient and standard errors? This type of study would benefit a longitudinal data, to answer the question, although the authors acknowledge the limitation. I would suggest toning down the conclusion as the results are from one time point only. In preparing your revisions, please bear in mind the appropriate CONSORT recommended reporting format for Randomised trial studies http://www.consort-statement.org/
VERSION 1 -AUTHOR RESPONSE
Reviewer: Andreas Knudsen, MD Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre Denmark These are minor details: 1) p.6 Statistical analysis: I find the statistics behind the comparison of the groups in Table 1 worth mentioning. Table  1 under the methods section (paragraph 2, page 6) 2)p. 4, l. 43 references 11-13 are old and pre-HAART. Maybe a sentence clarifying this would be appropriate. The reference 16 is refering to an HIV-study, not a study in the general population as stated.
Response-We have added description of the statistics behind the comparison of the groups in
Response-We have added a sentence denoting that references 11-13 were pre-HAART (Introduction, page 4). We also have edited the references mentioned in page 9 making sure that reference # 16 is not included in the list of references referring to the rule of heart rate and HRV in the general population.
Reviewer: Fowzia Ibrahim Statistician King's Musculoskeletal Clinical Trials Unit Department of Academic Rheumatology King's College London
The coefficient with 95% confidence intervals, for clinical audience, they would find difficult to understand standard errors in terms of the variability around the estimate.
Response-We have replaced standard error with the 95% confidence interval in all tables.
No ethics or consort was mentioned, although they reference previous publication that describes the method in more detail. I would suggest to briefly include a paragraph about the trial set up, ethics etc.
Response-We have added a sentence in the methods section (page 5) denting that ethical approval has been obtained from the IRB of all participating centers. Regarding the consort, we would like to highlight that this is a cross sectional analysis (as mentioned in the title) in which we utilized the baseline data of a clinical trial. Therefore, the consort is not applied here.
Statistical method
Was interaction between treatment and ECG been tested? Probably time from first prescription of ART might capture some of the effect but wondered if any interaction term was assessed in the model four?
Response-We do not fully understand what the reviewer means. ECG variables were the outcomes in the statistical models. Therefore, it would not be possible to examine interaction between treatment (an exposure variable) and ECG variables.
Since this data is arisen from Randomised trial, I wonder why the authors haven't sited the consort statement. There is no mention of how missing observations was dealt within the analysis? Response-as mentioned earlier, this is a cross sectional analysis (as mentioned in the title) in which we utilized the baseline data of a clinical trial. Therefore, the consort is not applied here.
We would be interested in further exploration of the differences in risk relationships between races. In particular, we would like to see the data for both races combined into a single model for each outcome with a test for the interaction between race and each outcome. Table 2 already includes the association of each race with the ECG outcome measures. Since the ECG variables are the outcomes in the models, we do not really understand what the reviewer mean by testing interaction between race and ECG variables.
Response-Supplementary
The baseline visit needs clarification. Was this the first available visit in clinic? Date of the first available ECG? Where the 3 outcome competing? Could a subject have all the three outcomes or 2 etc? If that was the case could a competing risk analyses be appropriate?
Response-Once again, this was a cross sectional study utilizing only baseline data. The baseline visit is the visit when all physical exam, blood tests and ECGs were conducted. The ECG outcomes are 3 different ECG variables form the same ECG at the baseline. Therefore, no competing risk analysis is needed.
Results Figure 1 -It will be helpful to see a comparison ( without statistical test, just the descriptive data) of the clinical variables of those patients with and without SDNN/rMSSD. Table (Supplementary Table 3 ) comparing the characteristics of those with and those without SDNN/rMSSD data There is some inconsistence with this figure compared to one of the authors previous publication ( Ref 16) . In that paper the authors report 646 subjects with a missing or poor quality of baseline ECG, while in this paper is only 207? But the number of subjects in the trial is the same 5472 in both articles. Could the authors explain the discrepancies? I would thought the subjects who qualify in this analysis should be those with baseline ECG ( i.e. 4,826-number from the old paper) then to subsequently restrict to the PI or NNRTI regiment?
Response-We have added a supplementary
Response-The differences in the number of ECGs excluded because of missing or poor quality of baseline in this paper compared to our paper ref# 6 is explained by when the exclusion was made. In this paper we excluded these ECGs out of 3778 participants (after excluding 1994 in the first step because of ART treatment). On the hand, in reference #16 the ECGs were excluded in the first step directly out of the overall participants (n=5472) Since p-values are included in table one, the test that is been used should be mentioned in the statically section. Response-We have added description of the statistics behind the comparison of the groups in Table  1 under the methods section (paragraph 2, page 6) I would recommend that the results in the table 2 and supplementary table two should be presented coefficient with 95% confidence intervals, instead of coefficient and standard errors?
Response-We have replaced standard error with the 95% confidence interval in all tables This type of study would benefit a longitudinal data, to answer the question, although the authors acknowledge the limitation. I would suggest toning down the conclusion as the results are from one time point only. Response-We realize the importance of the reviewer's comment. That is why we were very careful in the previous submission to avoid any causality wording and focus mainly on association (which is more appropriate for the cross sectional analysis).
In preparing your revisions, please bear in mind the appropriate CONSORT recommended reporting format for Randomised trial studies http://www.consort-statement.org/ Response-not applicable to this cross sectional analysis
